focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDNL.L Regulatory News (DNL)

  • There is currently no data for DNL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

24 Dec 2015 12:18

RNS Number : 2115K
Diurnal Group PLC
24 December 2015
 

 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

Diurnal Group Plc

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

X

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

3. Full name of person(s) subject to thenotification obligation: iii

OCEANWOOD CAPITAL MANAGEMENT LLP

4. Full name of shareholder(s)  (if different from 3.):iv

OCEANWOOD OPPORTUNITIES MASTER FUND

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

Transaction Date: 21st December 2015

Obligation to report: 24th of December 2015

6. Date on which issuer notified:

24th December 2015

7. Threshold(s) that is/are crossed orreached: vi, vii

Above 6% Threshold

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

ISIN:

GB00BDB6Q760

0

0

3,472,222

3,472,222

6.70%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix,

 

 

 

Nominal

Delta

 

 

Total (A+B+C)

Number of voting rights

Percentage of voting rights

3,472,222

6.70%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

 

 

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will cease to hold:

12. Date on which proxy holder will cease to hold voting rights:

13. Additional information:

We are breaching 6% threshold

14. Contact name:

Stephan Michaels

15. Contact telephone number:

+356 2248 6930

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLPGGAGPUPAGPC
Date   Source Headline
7th Sep 202212:00 pmRNSForm 8.5 (EPT/RI) - Diurnal Group plc
7th Sep 20229:58 amRNSForm 8.5 (EPT/RI)
7th Sep 20229:23 amRNSMole Valley Asset Management Ltd-Form 8.3 Diurnal
6th Sep 20221:36 pmRNSForm 8.5 (EPT/RI) - Diurnal Group plc
6th Sep 202212:00 pmRNSForm 8.5 (EPT/RI) - Diurnal Group plc
6th Sep 20229:04 amRNSForm 8.3 - [DIURNAL GROUP PLC]
5th Sep 20223:16 pmRNSForm 8.3 - Diurnal Group Plc
5th Sep 20221:36 pmRNSForm 8 (OPD) (Diurnal Group)
5th Sep 202212:00 pmRNSForm 8.5 (EPT/RI) - Diurnal Group plc
2nd Sep 20224:28 pmRNSForm 8 (OPD) (Neurocrine Biosciences, Inc.)
2nd Sep 20222:55 pmRNSForm 8.3 - Diurnal Group plc
2nd Sep 202212:00 pmRNSForm 8.5 (EPT/RI) - Diurnal Group plc
2nd Sep 20228:58 amRNSForm 8.5 (EPT/RI)
1st Sep 20223:12 pmRNSForm 8.3 - Diurnal Group plc
1st Sep 20221:20 pmRNSForm 8.3 - Diurnal Group Plc
1st Sep 202212:00 pmRNSForm 8.5 (EPT/RI) - Diurnal Group plc
1st Sep 202210:04 amRNSForm 8.5 (EPT/RI)
1st Sep 20229:38 amRNSForm 8.3 - [DIURNAL GROUP PLC]
1st Sep 20227:00 amRNSPostponement of R&D Day and Notice of Results
31st Aug 20223:20 pmRNSForm 8.3 - Diurnal Group plc
31st Aug 20222:03 pmRNSForm 8.3 - Diurnal Group PLC
31st Aug 202212:53 pmRNSForm 8.3 DIURNAL GROUP PLC
31st Aug 202212:00 pmRNSForm 8.5 (EPT/RI) - Diurnal Group plc
31st Aug 202211:56 amRNSForm 8.5 (EPT/RI) - Diurnal Group PLC
31st Aug 202211:55 amRNSForm 8.3 - Diurnal Group plc
31st Aug 202211:46 amGNWForm 8.3 - [Diurnal Group plc - 30 08 2022 - Opening Declaration] - (HHL)
31st Aug 20229:08 amRNSForm 8.3 - Diurnal Group PLC
30th Aug 202212:55 pmRNSForm 8.3 - DIURNAL GROUP PLC
30th Aug 202212:32 pmEQSForm 8.3 - Maitland Institutional Services Limited: Re Diurnal Group plc
30th Aug 20227:00 amRNSRECOMMENDED CASH ACQUISITION
26th Jul 20227:00 amRNSTrading Update
15th Jul 202212:04 pmRNSDirector Dealings
30th Jun 20221:29 pmRNSBlock Listing Six Monthly Return
7th Jun 20221:00 pmRNSDiurnal to present research at ENDO 2022
1st Jun 20227:00 amRNSFirst patient dosed in pivotal Phase 3 trial
23rd May 20228:41 amRNSCorrection: Presentation at ECE
23rd May 20227:00 amRNSPresentation at European Congress of Endocrinology
9th May 202212:49 pmRNSDirector Dealings
29th Apr 20223:37 pmRNSTotal Voting Rights
28th Apr 20227:00 amRNSDiurnal to present at Investor Evening
25th Apr 20227:00 amRNSDistribution agreement signed with EffRx
20th Apr 20227:00 amRNSDistribution agreement signed with Er-Kim
4th Apr 20227:00 amRNSDirectorate Change and Management Updates
1st Apr 20227:00 amRNSTotal Voting Rights
30th Mar 20227:00 amRNSDistribution agreement with Vector Pharma
22nd Mar 20224:35 pmRNSPrice Monitoring Extension
22nd Mar 20222:06 pmRNSSecond Price Monitoring Extn
22nd Mar 20222:00 pmRNSPrice Monitoring Extension
22nd Mar 20227:00 amRNSInterim Results
9th Mar 20227:00 amRNSInterim Results Investor Presentation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.